Objective To explore the clinical effect of intravenous infusion pump transfusion of pituitrin combined with phentolamine in the treatment of pulmonary tuberculosis hemoptysis. Method 48 cases of tuberculosis diagnosed by respiratory department from January 20 to January 2017 were divided into experimental group and control group according to the principle of random distribution. The patients in the experimental group were treated with intravenous infusion pump into pituitrin combined with phentol Ming treatment, the control group of patients with intravenous infusion pump into the pituitrin for treatment. Results The effective rate of the treatment group was 95.8 %, the hemoptysis time was (2.41±0.39) days, and the adverse reaction rate was 29.17% in the experimental group and the control group, and the curative effect was 75.00%, the statistical difference was statistically significant (P<0.05). Conclusion Intravenous infusion pump intake of pituitrin combined with phentolamine treatment of pulmonary tuberculosis hemoptysis in hemoptysis stop time, the effectiveness of treatment and the incidence of adverse reactions have significant advantages.%目的 探索静脉输液泵泵入垂体后叶素联合酚妥拉明治疗肺结核咯血的临床效果.方法 选择新疆医科大学第一附属医院2016年1月~2017年1月呼吸科收治的确诊为肺结核的48例患者为研究对象,按照随机分布原理将所有患者分为实验组和对照组,每组24例患者,对照组中患者静脉输液泵泵入垂体后叶素进行治疗,实验组中患者采用静脉输液泵泵入垂体后叶素联合酚妥拉明进行治疗.观察与统计实验组与对照组中患者的咯血停止时间、治疗有效率以及不良反应.结果 实验组的治疗有效率为95.8%,咯血停止时间为(2.41±0.39)d,不良反应率为29.17%;对照组患者的治疗有效率为75%,不良反应率为29.17%,咯血停止时间为(5.16±0.93)d,差异具有统计学意义(P<0.05).结论 静脉输液泵泵入垂体后叶素联合酚妥拉明治疗肺结核咯血在咯血停止时间、治疗有效率以及不良反应发生率方面都具有显著的优点.
展开▼
